Found: 12
Select item for more details and to access through your institution.
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2149040, doi. 10.1001/jamanetworkopen.2021.49040
- By:
- Publication type:
- Article
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 3, p. 1, doi. 10.1093/jncics/pkaa023
- By:
- Publication type:
- Article
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 225, doi. 10.3390/cancers16010225
- By:
- Publication type:
- Article
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4867, doi. 10.3390/cancers15194867
- By:
- Publication type:
- Article
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5173, doi. 10.3390/cancers14215173
- By:
- Publication type:
- Article
Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 10, p. 7033, doi. 10.1245/s10434-024-15670-6
- By:
- Publication type:
- Article
Marine omega‐3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 2, p. 380, doi. 10.1002/ijc.32113
- By:
- Publication type:
- Article
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 292, doi. 10.1093/oncolo/oyab025
- By:
- Publication type:
- Article
Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 610, doi. 10.1002/onco.13730
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 380, doi. 10.1634/theoncologist.2019-0874
- By:
- Publication type:
- Article
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 20, p. 3801, doi. 10.1002/cncr.33649
- By:
- Publication type:
- Article